ECSS
GILD icon

Eurizon Capital SGR SpA’s Gilead Sciences GILD Stock Holding History

Eurizon Capital SGR SpA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109M Buy
862,517
+75,286
+10% +$9.92M 0.29% 76
2026
Q1 		$109M Sell
787,231
-169,239
-18% -$23.7M 0.34% 66
2025
Q4 		$117M Buy
+956,470
New +$116M 0.37% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eurizon Capital SGR SpA's GILD Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Gilead Sciences (GILD) stake by 9.6% in Q2 2026, buying an estimated $9.92M and bringing the position to 862,517 shares worth $109M. The position accounts for 0.29% of the portfolio, ranked #76.

Eurizon Capital SGR SpA first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $117M in Q4 2025. 2,264 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Eurizon Capital SGR SpA held 862,517 shares of Gilead Sciences worth $109M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 75,286 Gilead Sciences shares in Q2 2026, an estimated $9.92M.
  • Gilead Sciences made up 0.29% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #76 holding.
  • Eurizon Capital SGR SpA first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Gilead Sciences position peaked at $117M in Q4 2025.
  • 2,264 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.